Found: 10
Select item for more details and to access through your institution.
Population Pharmacokinetic/Pharmacodynamic Modeling of the Effect of Abrocitinib on QT Intervals in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 9, p. 1036, doi. 10.1002/cpdd.1111
- By:
- Publication type:
- Article
Exposure-response modeling and clinical trial simulation of the effect of tolterodine on QT intervals in healthy volunteers.
- Published in:
- Drug Discoveries & Therapeutics, 2010, v. 4, n. 1, p. 44
- By:
- Publication type:
- Article
Disposition and safety of omapatrilat in subjects with renal impairment<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2000, v. 68, n. 3, p. 261, doi. 10.1067/mcp.2000.109033
- By:
- Publication type:
- Article
Population pharmacokinetic‐pharmacodynamic modelling of platelet time‐courses following administration of abrocitinib.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 8, p. 3856, doi. 10.1111/bcp.15334
- By:
- Publication type:
- Article
Effects of food on the clinical pharmacokinetics of anticancer agents: underlying mechanisms and implications for oral chemotherapy.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Oral Bioavailability and Disposition of [14C]Omapatrilat in Healthy Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2001, v. 41, n. 8, p. 833, doi. 10.1177/009127000104100803
- By:
- Publication type:
- Article
Population Pharmacokinetics of Abrocitinib in Healthy Individuals and Patients with Psoriasis or Atopic Dermatitis.
- Published in:
- Clinical Pharmacokinetics, 2022, v. 61, n. 5, p. 709, doi. 10.1007/s40262-021-01104-z
- By:
- Publication type:
- Article
Correction to: Population Pharmacokinetics of Abrocitinib in Healthy Individuals and Patients with Psoriasis or Atopic Dermatitis.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Effects of Renal Impairment on the Pharmacokinetics of Abrocitinib and Its Metabolites.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 4, p. 505, doi. 10.1002/jcph.1980
- By:
- Publication type:
- Article
Effects of Hepatic Impairment on the Pharmacokinetics of Abrocitinib and Its Metabolites.
- Published in:
- Journal of Clinical Pharmacology, 2021, v. 61, n. 10, p. 1311, doi. 10.1002/jcph.1858
- By:
- Publication type:
- Article